MedTrace Logo

Pubertal Replacement In Boys Study Nebido and Testoviron Depot Treatment

NCT05417035 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2022-06-14

No results posted yet for this study

Summary

In this prospective open clinical study, Pubertal Replacement in Boys Study (PRIBS), boys 14-16 years with delayed puberty in terms of slow pubertal progression, were randomized to SoC treatment with TE: Testostoviron depot® 75 mg intramuscularly (i.m) / month (6 injections), or low dose TU: Nebido® 250mg i.m. / 3 months (2 injections). Our goal was to implement a study similar to clinical routine.

Conditions

  • Puberty Delayed

Interventions

DRUG

Nebido

To evaluate if traditional treatment induces puberty similary to newer treatment

Sponsors & Collaborators

  • NU-Hospital Organization, Sweden

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-01
Primary Completion
2019-08-01
Completion
2020-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05417035 on ClinicalTrials.gov